Effect of Aerobic Exercise on Side Effects of Disease Modifying Therap
Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 14 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Physical exercise training
What it measured
Main measures
Multiple Sclerosis Fatigue
FatigueQuality of Life
Quality of life (reported by participants)Injection site visual analog scale (0-10)
Safety
Who could take part
Relapsing MS · 18 to 65
Show the full criteria
Inclusion criteria
* Recent diagnosis of relapsing remitting multiple sclerosis on treatment with b1b-interferon disease modifying treatment
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to investigate the effects and tolerability of exercise on side effects of injectable disease modifying treatments in multiple sclerosis. The investigators main hypothesis is that controlled exercise is safe and can be well tolerated in patients with multiple sclerosis and it can improve disease modifying treatment related side effects such as fatigue.
Loading reviews and guidelines…
History
Started
May 2010
Main results due
Jun 2012
Finished
Jun 2012